Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C. (Q45203372)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621141%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621141%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

main subject

liver transplantation

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621141%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Ribes D

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621141%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Sandres-Saune K

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621141%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Suc B

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621141%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Barange K

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621141%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Cointault O

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621141%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Lavayssiere L

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621141%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Durand D

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621141%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Izopet J

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621141%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Rostaing L

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621141%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

language of work or name

English

0 references

publication date

1 November 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621141%20AND%20SRC:MED&resulttype=core&format=json

Transplantation Proceedings

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621141%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621141%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621141%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

2757-2761

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621141%20AND%20SRC:MED&resulttype=core&format=json

The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.10.003

Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.10.003

Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.10.003

Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.10.003

Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.10.003

Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.10.003

The role of immunosuppression in recurrence of hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.10.003

A longitudinal analysis of hepatitis C virus replication following liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.10.003

Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.10.003

Immunosuppression with calcineurin inhibitors and polyclonal antibodies in liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.10.003

Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.10.003

Prospective evaluation of a quadruple therapy based on tacrolimus after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.10.003

Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.10.003

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.10.003

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.10.003

Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.10.003

10.1016/J.TRANSPROCEED.2004.10.003

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15621141%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference